Wegovy Pill vs Injection: Which Is Right for You?

Wegovy pill vs injection compares two forms of the same semaglutide treatment rather than two different medicines. The Wegovy tablet and injection contain the same active ingredient, semaglutide. The tablet is taken once daily with specific fasting and timing requirements, while the injection is administered once weekly without food-related restrictions. The key differences also include absorption, storage and how easily each option fits into daily life. [1, 2, 3]

If you are trying to lose weight, the Wegovy pill may appeal if you dislike needles, while the Wegovy injection may suit you if you prefer a weekly dosing schedule without fasting rules. Separate clinical trials have reported substantial weight loss with both the 25 mg tablet and the 2.4 mg injection, but the results cannot be directly compared because the formulations have not been tested against each other in the same trial. [2, 3, 4, 5]

This guide compares Wegovy pill vs injection treatment, including dosing, side effects, weight loss, storage, cost and switching. A clinical assessment is needed before either weight loss medication is prescribed.

The key differences between the Wegovy pill and injection

The main differences are convenience and absorption. The Wegovy pill and injection are both prescription-only medicines. Both the pill and injection use semaglutide, but they do not reach the bloodstream in the exact same way.

Feature	Wegovy pill	Wegovy injection
Form	Daily pill	Weekly injection
Maintenance dose	25 mg once daily	2.4 mg once weekly; 7.2 mg may be used in some adults with obesity
Food rules	Empty stomach after at least 8 hours fasting; wait at least 30 minutes afterwards	No fasting requirement
Storage	No special temperature conditions; keep in original blister	Refrigerate before first use; specific in-use rules apply
Absorption	More variable	More predictable
Needle needed	No	Yes

The injection Wegovy pill comparison can look confusing because the milligram doses differ. The injectable version avoids the pill's fasting rules. The oral formulation requires a substantially higher nominal dose because only a small proportion of semaglutide is absorbed through the gastrointestinal tract.

What is the Wegovy injection?

The Wegovy injection is one of the prescription weight loss injections available in the UK and contains semaglutide, which is given under the skin once a week. It can be prescribed privately to eligible patients; NHS access is narrower and depends on NICE criteria and local services. [3, 6]

How the injection works in the body

Injected semaglutide is a GLP-1 receptor agonist that helps regulate appetite and reduce hunger.

The active ingredient is the same as in the pill. What differs is delivery: injectable semaglutide is absorbed from under the skin, while oral semaglutide has to cross the stomach lining.

Wegovy injection dosage schedule

The Wegovy injection dosage schedule starts at 0.25 mg once weekly and usually increases every four weeks through 0.5 mg, 1 mg and 1.7 mg to a 2.4 mg maintenance dose. For adult weight management in patients with obesity, the injection dose can be increased to 7.2 mg once weekly after at least four weeks on 2.4 mg if needed. [3, 7]

Dose escalation helps reduce gastrointestinal side effects. The higher dose is not automatically right for everyone, and dose increases should follow the prescriber's instructions.

How to use the Wegovy injection pen

Use the Wegovy pen exactly as shown in the product instructions and by your healthcare professional. The weekly injection is given under the skin of the abdomen, thigh or upper arm. The injection site can be changed each week.

Do not inject into a muscle or vein. If you have skin irritation or other injection site reactions that are persistent or severe, speak to your prescriber. Injection site reactions are recognised with injected semaglutide.

What is the Wegovy pill?

The Wegovy pill is once-daily oral semaglutide, approved by the MHRA in June 2026 as the first UK GLP-1 tablet specifically for weight loss.

For eligible patients who prefer tablets, the Wegovy pill in UK offers a needle-free alternative to weight loss injections, but daily dosing comes with stricter timing rules.

Wegovy should not be confused with Rybelsus. Both contain semaglutide, but Rybelsus is licensed for adults with insufficiently controlled type 2 diabetes, while Wegovy tablets are licensed for weight control. [2, 8]

How the pill works in the body

Oral semaglutide acts on the same GLP-1 receptor as the injection. Both the Wegovy pill and injection therefore work through semaglutide rather than different active drugs.

The tablet is co-formulated with salcaprozate sodium, which helps semaglutide to be absorbed through the stomach lining. Even with this absorption enhancer, only a small proportion of the oral dose reaches the systemic circulation, and absorption is more sensitive to administration conditions than with the injection.

The 25 mg oral tablet produces an average steady-state semaglutide concentration comparable with the 2.4 mg weekly injection. The Wegovy tablets SmPC, available through the Electronic Medicines Compendium, reports average concentrations of about 77 nmol/L with the 25 mg pill and 75 nmol/L with the 2.4 mg injection.

Wegovy pill dosage schedule

The Wegovy pill dosage schedule begins at 1.5 mg once daily. After at least one month, the Wegovy pill dose rises to 4 mg, then 9 mg, then the 25 mg maintenance dose, spending at least one month at each step. If needed, treatment can remain at a previous dose level.

Only one tablet should be taken per day. Taking more than one tablet to create a higher dose is not recommended, and you should never take a double dose to compensate for a missed dose.

How to take the Wegovy pill: fasting and timing rules

Take the daily tablet on an empty stomach after a fasting period of at least eight hours. Swallow it whole with up to 120 mL of water. Do not split, crush or chew the tablet.

After taking oral Wegovy, wait at least 30 minutes before eating, drinking or taking other medications. Waiting less than 30 minutes reduces absorption. These strict timing and dosing instructions are important because food, water volume and tablets taken at the same time can affect how much oral semaglutide is absorbed.

This also works in the other direction: because nothing else can be taken for 30 minutes, any other morning medication has to be pushed back. Anyone taking levothyroxine, which has its own empty-stomach requirement, or other medicines with strict timing should check with their prescriber how the two schedules can be fitted together.

Which produces better weight loss results?

Unfortunately, separate studies do not prove that the 2.4 mg injection is more effective than the 25 mg pill. The evidence comes from different studies, so average weight loss figures should be compared cautiously, and individual results vary.

Wegovy injection weight loss results

In STEP 1, published in the New England Journal of Medicine, the 2.4 mg weekly injection produced an average weight loss of 14.9% of body weight after 68 weeks, compared with 2.4% with placebo. [5]

The STEP UP clinical trial, published in The Lancet Diabetes & Endocrinology, found average weight loss of 18.7% of body weight with the 7.2 mg injection at 72 weeks, versus 15.6% with 2.4 mg and 3.9% with placebo. This higher dose is only for some adults with obesity. [9]

Wegovy pill weight loss results

The OASIS 4 clinical trial of the 25 mg daily pill was published in the New England Journal of Medicine. At week 64, average weight loss was 13.6% with the Wegovy pill versus 2.2% with placebo. [4]

About 27.5% of participants taking oral semaglutide achieved at least 20% weight loss. A separate analysis estimating weight loss assuming continued treatment and no additional anti-obesity medication projected an average reduction of 16.6%.

Is the difference significant?

These separate studies do not prove that the 2.4 mg injection is more effective than the 25 mg pill. OASIS 4 and STEP 1 differed in participants and design, so a head-to-head clinical trial would be needed for a reliable comparison.

The 7.2 mg injection produced greater average weight loss in STEP UP, but has different eligibility and safety considerations. In a Wegovy pill vs injection decision, results depend on dose, adherence, tolerability and individual response.

Are the Wegovy pills as effective as the injection? Clinical trials have shown substantial weight loss with both 25 mg oral semaglutide and 2.4 mg injected semaglutide, but the separate trials do not establish that the two formulations are equally effective. Individual results vary, and the 64- and 68-week studies cannot predict how quickly someone will lose weight or how much they will lose in three months.

Side effects: pill vs injection

The most common side effects of both forms are gastrointestinal because both use semaglutide. In OASIS 4, nausea occurred in 46.6% of Wegovy pill users, vomiting in 30.9%, diarrhoea in 17.6% and constipation in 20.1%. With the 2.4 mg Wegovy injection across the STEP programme, nausea occurred in 43.9%, diarrhoea in 29.7%, vomiting in 24.5% and constipation in 24.2%.

Dyspepsia (indigestion) had a higher frequency category with the tablet in OASIS 4. The injection has route-specific effects such as injection site reactions and skin irritation around an injection site, which do not apply to a tablet.

Both forms can have less common but important risks, including pancreatitis and gallbladder disease. One precaution applies to both forms regardless of route: semaglutide slows gastric emptying, so the stomach may still contain food after the usual pre-operative fasting, and the MHRA advises telling the surgical team and anaesthetist before any procedure involving general anaesthesia or deep sedation. Our guide to Wegovy pill side effects covers the tablet in more detail; medical history still matters when choosing treatment.

How to store and travel with Wegovy

Wegovy tablets are simpler to store. They should stay in their original blister to protect them from moisture and light, and no special temperature storage conditions are required.

Wegovy injection pens should be refrigerated at 2°C to 8°C before use and must not be frozen. The 0.25 mg to 2.4 mg multi-dose FlexTouch pens can be kept for six weeks below 30°C or refrigerated once in use. The single-dose 7.2 mg pen has different storage instructions and can be kept unrefrigerated for up to 28 days at no more than 30°C.

When travelling, keep the medication in its original packaging and follow the supplied storage instructions. If a pen has been left out of the fridge, check it against the in-use limits above rather than assuming it must be discarded – and if the time or temperature has been exceeded, or the liquid looks cloudy or contains particles, ask a pharmacist before using it.

How much does each cost in the UK?

Private Wegovy costs vary by provider and dose. As of August 2026, Apomeds lists the Wegovy injection from £97.93 for four weeks of treatment. The 1.7 mg injection dose costs £161.00 and the 2.4 mg maintenance dose £218.73. These prices include the medication, delivery and the Apo Global platform fee, but exclude a doctor’s fee where applicable.

For the oral form, reported UK private launch prices for Wegovy tablets in July 2026 ranged from around £69 to £189 per month, depending on the dose. The pill may therefore cost more or less than the injection depending on the strength and provider. Prices may change, and providers can include different levels of prescribing, consultation, delivery and ongoing support, so it is worth comparing the total treatment cost rather than the medication price alone.

Which is right for you?

The best treatment depends on how the medication fits your routine. The pill may suit someone with needle phobia who can reliably follow its fasting rules. Someone who normally eats breakfast, drinks coffee or takes other oral medicines soon after waking may find that routine less convenient, while the weekly injection avoids those timing restrictions.

The injection also has more direct evidence for cardiovascular risk reduction in people with established cardiovascular disease and overweight or obesity. The SELECT evidence relates to semaglutide 2.4 mg injection, and NICE recommends this use within the marketing authorisation. [3, 10] This does not establish that the Wegovy pill lacks cardiovascular benefit; rather, the cardiovascular outcome evidence and current NICE recommendation apply to once-weekly injectable semaglutide.

Your medical history, other medications, previous side effects, preferred routine and weight loss journey all matter. Neither formulation should be used during pregnancy. If pregnancy is planned, semaglutide should generally be discontinued at least two months beforehand because of its long half-life. Other treatments, including Mounjaro, may also be considered after individual assessment. If you prefer semaglutide, you can discuss Wegovy online in UK options with a regulated prescriber.

Can you switch between the two?

Yes, switching can be possible, but it should be planned by the prescriber rather than calculated from milligram numbers. The effect cannot be predicted in the exact same way for everyone because oral absorption is more variable.

Current product information says patients taking semaglutide injection 2.4 mg once weekly can transition to the Wegovy pill dose of 25 mg once daily, starting the tablets one week after the last injection dose. It does not provide a simple milligram-for-milligram conversion for every injection dose.

Because the medication stays in circulation for weeks, do not combine forms or create your own overlap. A clinical assessment is important after an interruption.

FAQs

These answers cover common practical questions about Wegovy pill vs injection treatment.

Is the Wegovy pill available in UK pharmacies now?

Yes. The Wegovy pill is licensed in the UK and is available privately through some UK pharmacies, subject to stock and a successful clinical assessment. [1, 11]

Can I get the Wegovy pill on the NHS?

No, not currently for weight management. The MHRA stated when it approved the pill in June 2026 that it was not available through the NHS and that NHS use would follow established processes, including NICE evaluation. Current NICE weight-management recommendations cover semaglutide injection under specific criteria, not the new Wegovy tablets.

Why is the pill dose so much higher than the injection?

Because only a small proportion of oral semaglutide is absorbed. Its estimated absolute bioavailability is around 1% to 2%, and absorption is more variable than with the semaglutide injection. The higher Wegovy pill dose compensates for this limited oral absorption; 25 mg by mouth is not equivalent to injecting 25 mg.

What if I miss a dose of the pill or injection?

For the pill, skip the missed dose and take the next dose the following day. Do not take a double dose or two tablets on the same day.

For the weekly injection, take a missed dose as soon as possible if no more than five days have passed. If more than five days have passed, skip it and take the next dose on the usual day.

Can anyone switch from the injection to the pill?

No. Switching is not automatic for everyone. Oral product information specifically describes transitioning from injected semaglutide 2.4 mg weekly to 25 mg oral Wegovy one week later, but suitability still depends on current treatment, tolerance, medical history and the prescriber's assessment.